SlideShare a Scribd company logo
1 of 11
Download to read offline
An agency of the European Union
Presented by Pascal Venneugues (Pharmaceutical Quality) and Christelle Bouygues (Regulatory Affairs)
Human Medicines Division, EMA
Drug-device combination
products under the MDR
EMA 1-year experience
8th Meeting of the Industry Stakeholder Platform on Centralised Procedure, 27 June 2022
Classified as public by the European Medicines Agency
Outline
MDR implementation
• What have we observed?
o Experiences and challenges
• What is ongoing and what is next?
1
Classified as public by the European Medicines Agency
What have we observed?
• Changes and inconsistencies in the qualification and classification (e.g.
some medical devices/medical device parts with impact on evidence provided,
‘add-on’ smart device (to integral device) and of connected App as MD software,
accessory to MD vs not MD)
• Need for adjustment of economic operator roles (medicinal product applicant
vs medical device manufacturer)
• MAHs seeking advice to EMA on lifecycle management of integral device
changes
• Proposals from applicant/MAH to address device labelling requirement of co-
packaged devices
2
Classified as public by the European Medicines Agency
Article 117: Experiences and challenges
Example of single-use prefilled syringe (PFS) without needle
 Similar intended use but classified as I, Is, IIa or III by manufacturers / MAA applicants
 A Notified Body issued an Opinion for a PFS they considered as Class I  remit?
 Co-packaged or separately-obtained CE-marked needle outside the scope of the PFS NB
Opinion
 Any benefit for patients and healthcare professionals to provide a PFS without needle?
 Attaching a suitable needle before administration represents additional risks
 Article 117 matters should be discussed and agreed during pre-submission
1. Device classification issues and impact on NB Opinion requirement
3
Classified as public by the European Medicines Agency
Article 117: Experiences and challenges
2. Partial compliance with relevant GSPRs
The NB Opinion is binding to CHMP
 Lack of full compliance with the relevant GSPRs impacts the approvability of
the MAA, line extension and variation
 CHMP cannot bypass the NB Opinion
 CHMP cannot follow-up on deficiencies identified in the NB Opinion
 In case of partial compliance, the applicant should liaise with the Notified Body to
address the deficiencies and provide a revised NB Opinion before CHMP Opinion
 Recommendation to have the final NB Opinion ready at submission to avoid delays
But in practice many applicants file the MAA/line extension and NB Opinion applications in
parallel to save time
4
Classified as public by the European Medicines Agency
Article 117: Experiences and challenges
 Change affecting design, performance, safety characteristics, intended purpose of
the medical device
 Impact on QTPP, DDC CQAs, DDC overall control strategy, delivery, IFUs
BUT:
 No legal definition of a substantial/significant change to a medical device
 Applicability of MDCG 2020-3, ISO 20069 or TeamNB guidance?
 Different perspectives on the importance/relevance of a change
 Does a change in intended use (e.g. new paediatric indication) always qualify as a
substantial change?  It depends!
3. Lifecycle management: what is a “substantial” change?
5
Classified as public by the European Medicines Agency
Article 117: Experiences and challenges
 Advising on the need for new or revised NB Opinion for device changes falls
outside EMA remit
 But industry cannot consult a NB if they did not previously assess the device
(due to their legal mandate)
 New or revised NB Opinion, if required for device changes, expected in the line
extension/variation based on MAH risk assessment. If not provided, a justification is
expected in the dossier
 Classification guideline on variations lacks granularity for device changes
 “Substantial” device-related changes not defined
 4 scenarios for devices changes: variation (yes/no); new/revised NBOp (yes/no)
 ICH Q12 example to define Established Conditions for a PFS: work in progress
 Should inform the revision of the Classification guideline (Pharma Strategy)
4. Lifecycle management: challenges
6
Classified as public by the European Medicines Agency
Art 117: Experiences and challenges
7
 Numerous variations to remove declaration of conformity and CE-mark for
some device components (part of existing integral drug-device combinations or co-
packaged device)
 Device manufacturers no longer classifying a number of previous class Inm, ns, nu,
devices as medical devices and removing declaration of conformity and CE-mark (e.g.,
for syringe system components; dosing cup for water for reconstitution)
 What evidence to show compliance with GSPR?
 For MD or accessories to MD, evidence needed. Hence if to be issued after 26 May
2021 even for an existing integral device, either a DoC, EU-certificate or a NB
opinion in accordance with MDR is required (but not a kind of conformance
statement by the MAH)
5. Qualification and proof of compliance with MDR
Classified as public by the European Medicines Agency
EMA/CMDh exchanges on MDR implementation to share
cases/industry requests and develop harmonised way forward
8
Ongoing review of Industry comments
(post-publication of Q&A update, final Quality guideline
and current experience)
Plan for an update of the Q&A on MDR/IVDR
implementation in 2022
Plan to enhance training on MDR
What is ongoing and what is next?
Classified as public by the European Medicines Agency
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Further information
Follow us on @EMA_News
Thank you for your attention
Classified as public by the European Medicines Agency
MDR implementation – Recap on state of play
Medicinal products used in combination with a medical device (Art 117)
• MDR entered into application on 26th May 2021
• Almost 1-year experience with the transitioning from MDD to MDR
10
MDR applies
since 26 May
2021
Update of the Questions and
answers on implementation of
the medical devices and in vitro
diagnostic medical devices
Regulations (June 2021)
Publication of the final
Guideline on quality
documentation for
medicinal products when
used with a medical device
(July 2021)
1-year
experience

More Related Content

Similar to presentation-ema-experience-mdr-implementation_en.pdf

TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Australia
 
International Overview & Future Medical Devices Regulations
International Overview & Future   Medical Devices RegulationsInternational Overview & Future   Medical Devices Regulations
International Overview & Future Medical Devices Regulationsmdbio2009
 
Eu Regulatory & Quality Environment- Abhishek Raval
Eu Regulatory & Quality Environment- Abhishek RavalEu Regulatory & Quality Environment- Abhishek Raval
Eu Regulatory & Quality Environment- Abhishek RavalAbhishekRaval16
 
Clinical Trial Regulation EU No. 536/2014
Clinical Trial Regulation EU No. 536/2014Clinical Trial Regulation EU No. 536/2014
Clinical Trial Regulation EU No. 536/2014Ivowen Limited
 
Clinicals In The Uk 26 January 2009
Clinicals In The Uk   26 January 2009Clinicals In The Uk   26 January 2009
Clinicals In The Uk 26 January 2009Colin Rylett
 
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device RegulationTuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device RegulationStefano Bolletta
 
New medical device regulation: implications for medical device manufacturers
New medical device regulation: implications for medical device manufacturersNew medical device regulation: implications for medical device manufacturers
New medical device regulation: implications for medical device manufacturersPEPGRA Healthcare
 
Eu hot topics alliance presentation
Eu hot topics alliance presentationEu hot topics alliance presentation
Eu hot topics alliance presentationErik Vollebregt
 
Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3Erik Vollebregt
 
Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2Erik Vollebregt
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...ulmedical
 
Vitafoods eu clinical trials regulation
Vitafoods   eu clinical trials regulationVitafoods   eu clinical trials regulation
Vitafoods eu clinical trials regulationAxon Lawyers
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingvineet gupta
 
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesThe Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesEuropean Industrial Pharmacists Group
 
Changing medical device regulations in Europe and the U.S.
Changing medical device regulations in Europe and the U.S.Changing medical device regulations in Europe and the U.S.
Changing medical device regulations in Europe and the U.S.Maetrics
 
Investigational medicinal product dossier
Investigational medicinal product dossierInvestigational medicinal product dossier
Investigational medicinal product dossierMayuriGhavate
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Euclarityeye
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwellhealthcareisi
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationTGA Australia
 
The Value of Integrated Care
The Value of Integrated CareThe Value of Integrated Care
The Value of Integrated CareAndrea MANTOVANI
 

Similar to presentation-ema-experience-mdr-implementation_en.pdf (20)

TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
 
International Overview & Future Medical Devices Regulations
International Overview & Future   Medical Devices RegulationsInternational Overview & Future   Medical Devices Regulations
International Overview & Future Medical Devices Regulations
 
Eu Regulatory & Quality Environment- Abhishek Raval
Eu Regulatory & Quality Environment- Abhishek RavalEu Regulatory & Quality Environment- Abhishek Raval
Eu Regulatory & Quality Environment- Abhishek Raval
 
Clinical Trial Regulation EU No. 536/2014
Clinical Trial Regulation EU No. 536/2014Clinical Trial Regulation EU No. 536/2014
Clinical Trial Regulation EU No. 536/2014
 
Clinicals In The Uk 26 January 2009
Clinicals In The Uk   26 January 2009Clinicals In The Uk   26 January 2009
Clinicals In The Uk 26 January 2009
 
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device RegulationTuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
Tuv sud-ivdr-infosheet - EU’s In Vitro Diagnostic Medical Device Regulation
 
New medical device regulation: implications for medical device manufacturers
New medical device regulation: implications for medical device manufacturersNew medical device regulation: implications for medical device manufacturers
New medical device regulation: implications for medical device manufacturers
 
Eu hot topics alliance presentation
Eu hot topics alliance presentationEu hot topics alliance presentation
Eu hot topics alliance presentation
 
Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3Eu hot topics alliance presentation 3
Eu hot topics alliance presentation 3
 
Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2Eu hot topics alliance presentation 2
Eu hot topics alliance presentation 2
 
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
“CFDA Registration – Market Access Before Investment” delivered by Tim Lin, T...
 
Vitafoods eu clinical trials regulation
Vitafoods   eu clinical trials regulationVitafoods   eu clinical trials regulation
Vitafoods eu clinical trials regulation
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packging
 
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesThe Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified Medicines
 
Changing medical device regulations in Europe and the U.S.
Changing medical device regulations in Europe and the U.S.Changing medical device regulations in Europe and the U.S.
Changing medical device regulations in Europe and the U.S.
 
Investigational medicinal product dossier
Investigational medicinal product dossierInvestigational medicinal product dossier
Investigational medicinal product dossier
 
Marketing Authorization In The Eu
Marketing Authorization In The EuMarketing Authorization In The Eu
Marketing Authorization In The Eu
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwell
 
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulationDevices Sponsor Information Day: 0 - Developments in medical device regulation
Devices Sponsor Information Day: 0 - Developments in medical device regulation
 
The Value of Integrated Care
The Value of Integrated CareThe Value of Integrated Care
The Value of Integrated Care
 

More from Balaji Kuzhandhaivelu

More from Balaji Kuzhandhaivelu (6)

usp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptxusp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptx
 
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptxMICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
 
BET.pptx
BET.pptxBET.pptx
BET.pptx
 
pharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdfpharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdf
 
general-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.pptgeneral-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.ppt
 
1116 Added.pdf
1116 Added.pdf1116 Added.pdf
1116 Added.pdf
 

Recently uploaded

Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...
Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...
Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...gragteena
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...Gfnyt
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...gurkirankumar98700
 
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabad
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in FaridabadNepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabad
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabadgragteena
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Call Girls Service Chandigarh Ayushi
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Sheetaleventcompany
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171Call Girls Service Gurgaon
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Call Girls Noida
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Vipesco
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Roomdivyansh0kumar0
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Niamh verma
 
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunNiamh verma
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipurgragmanisha42
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋Sheetaleventcompany
 
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaHot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaRussian Call Girls in Ludhiana
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...Call Girls Noida
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Memriyagarg453
 

Recently uploaded (20)

Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...
Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...
Call Girls Service Charbagh { Lucknow Call Girls Service 9548273370 } Book me...
 
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...Bangalore call girl  👯‍♀️@ Simran Independent Call Girls in Bangalore  GIUXUZ...
Bangalore call girl 👯‍♀️@ Simran Independent Call Girls in Bangalore GIUXUZ...
 
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Kolkata Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8923113531 ...
 
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabad
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in FaridabadNepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabad
Nepali Escort Girl * 9999965857 Naughty Call Girls Service in Faridabad
 
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...Jalandhar  Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
Jalandhar Female Call Girls Contact Number 9053900678 💚Jalandhar Female Call...
 
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Mumbai Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
 
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171VIP Call Girl Sector 32 Noida Just Book Me 9711199171
VIP Call Girl Sector 32 Noida Just Book Me 9711199171
 
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
Vip sexy Call Girls Service In Sector 137,9999965857 Young Female Escorts Ser...
 
Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510Krishnagiri call girls Tamil aunty 7877702510
Krishnagiri call girls Tamil aunty 7877702510
 
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130  Available With RoomVIP Kolkata Call Girl New Town 👉 8250192130  Available With Room
VIP Kolkata Call Girl New Town 👉 8250192130 Available With Room
 
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
Call Girls Service Chandigarh Gori WhatsApp ❤7710465962 VIP Call Girls Chandi...
 
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girls Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
 
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
💚😋Chandigarh Escort Service Call Girls, ₹5000 To 25K With AC💚😋
 
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In LudhianaHot  Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
Hot Call Girl In Ludhiana 👅🥵 9053'900678 Call Girls Service In Ludhiana
 
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
pOOJA sexy Call Girls In Sector 49,9999965857 Young Female Escorts Service In...
 
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near MeVIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
VIP Call Girls Noida Sia 9711199171 High Class Call Girl Near Me
 

presentation-ema-experience-mdr-implementation_en.pdf

  • 1. An agency of the European Union Presented by Pascal Venneugues (Pharmaceutical Quality) and Christelle Bouygues (Regulatory Affairs) Human Medicines Division, EMA Drug-device combination products under the MDR EMA 1-year experience 8th Meeting of the Industry Stakeholder Platform on Centralised Procedure, 27 June 2022
  • 2. Classified as public by the European Medicines Agency Outline MDR implementation • What have we observed? o Experiences and challenges • What is ongoing and what is next? 1
  • 3. Classified as public by the European Medicines Agency What have we observed? • Changes and inconsistencies in the qualification and classification (e.g. some medical devices/medical device parts with impact on evidence provided, ‘add-on’ smart device (to integral device) and of connected App as MD software, accessory to MD vs not MD) • Need for adjustment of economic operator roles (medicinal product applicant vs medical device manufacturer) • MAHs seeking advice to EMA on lifecycle management of integral device changes • Proposals from applicant/MAH to address device labelling requirement of co- packaged devices 2
  • 4. Classified as public by the European Medicines Agency Article 117: Experiences and challenges Example of single-use prefilled syringe (PFS) without needle  Similar intended use but classified as I, Is, IIa or III by manufacturers / MAA applicants  A Notified Body issued an Opinion for a PFS they considered as Class I  remit?  Co-packaged or separately-obtained CE-marked needle outside the scope of the PFS NB Opinion  Any benefit for patients and healthcare professionals to provide a PFS without needle?  Attaching a suitable needle before administration represents additional risks  Article 117 matters should be discussed and agreed during pre-submission 1. Device classification issues and impact on NB Opinion requirement 3
  • 5. Classified as public by the European Medicines Agency Article 117: Experiences and challenges 2. Partial compliance with relevant GSPRs The NB Opinion is binding to CHMP  Lack of full compliance with the relevant GSPRs impacts the approvability of the MAA, line extension and variation  CHMP cannot bypass the NB Opinion  CHMP cannot follow-up on deficiencies identified in the NB Opinion  In case of partial compliance, the applicant should liaise with the Notified Body to address the deficiencies and provide a revised NB Opinion before CHMP Opinion  Recommendation to have the final NB Opinion ready at submission to avoid delays But in practice many applicants file the MAA/line extension and NB Opinion applications in parallel to save time 4
  • 6. Classified as public by the European Medicines Agency Article 117: Experiences and challenges  Change affecting design, performance, safety characteristics, intended purpose of the medical device  Impact on QTPP, DDC CQAs, DDC overall control strategy, delivery, IFUs BUT:  No legal definition of a substantial/significant change to a medical device  Applicability of MDCG 2020-3, ISO 20069 or TeamNB guidance?  Different perspectives on the importance/relevance of a change  Does a change in intended use (e.g. new paediatric indication) always qualify as a substantial change?  It depends! 3. Lifecycle management: what is a “substantial” change? 5
  • 7. Classified as public by the European Medicines Agency Article 117: Experiences and challenges  Advising on the need for new or revised NB Opinion for device changes falls outside EMA remit  But industry cannot consult a NB if they did not previously assess the device (due to their legal mandate)  New or revised NB Opinion, if required for device changes, expected in the line extension/variation based on MAH risk assessment. If not provided, a justification is expected in the dossier  Classification guideline on variations lacks granularity for device changes  “Substantial” device-related changes not defined  4 scenarios for devices changes: variation (yes/no); new/revised NBOp (yes/no)  ICH Q12 example to define Established Conditions for a PFS: work in progress  Should inform the revision of the Classification guideline (Pharma Strategy) 4. Lifecycle management: challenges 6
  • 8. Classified as public by the European Medicines Agency Art 117: Experiences and challenges 7  Numerous variations to remove declaration of conformity and CE-mark for some device components (part of existing integral drug-device combinations or co- packaged device)  Device manufacturers no longer classifying a number of previous class Inm, ns, nu, devices as medical devices and removing declaration of conformity and CE-mark (e.g., for syringe system components; dosing cup for water for reconstitution)  What evidence to show compliance with GSPR?  For MD or accessories to MD, evidence needed. Hence if to be issued after 26 May 2021 even for an existing integral device, either a DoC, EU-certificate or a NB opinion in accordance with MDR is required (but not a kind of conformance statement by the MAH) 5. Qualification and proof of compliance with MDR
  • 9. Classified as public by the European Medicines Agency EMA/CMDh exchanges on MDR implementation to share cases/industry requests and develop harmonised way forward 8 Ongoing review of Industry comments (post-publication of Q&A update, final Quality guideline and current experience) Plan for an update of the Q&A on MDR/IVDR implementation in 2022 Plan to enhance training on MDR What is ongoing and what is next?
  • 10. Classified as public by the European Medicines Agency Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 Further information Follow us on @EMA_News Thank you for your attention
  • 11. Classified as public by the European Medicines Agency MDR implementation – Recap on state of play Medicinal products used in combination with a medical device (Art 117) • MDR entered into application on 26th May 2021 • Almost 1-year experience with the transitioning from MDD to MDR 10 MDR applies since 26 May 2021 Update of the Questions and answers on implementation of the medical devices and in vitro diagnostic medical devices Regulations (June 2021) Publication of the final Guideline on quality documentation for medicinal products when used with a medical device (July 2021) 1-year experience